Description
Hyplon (Zaleplon) 10 mg
Hyplon 10 mg is a brand of zaleplon, a short-acting, non-benzodiazepine hypnotic medicine used for insomnia, particularly when the main problem is difficulty falling asleep. Regulatory product information for zaleplon describes it as a prescription sleep medicine with rapid onset and a short duration of action.
Active Ingredient and Medicine Class
The verified active ingredient is zaleplon. It belongs to the sedative-hypnotic group of medicines and is commonly described as a non-benzodiazepine hypnotic. It is chemically distinct from benzodiazepines but acts on the same general inhibitory receptor system in the brain.
Established Medical Uses
Zaleplon is established for the short-term management of insomnia, especially sleep-onset insomnia, where falling asleep is the principal difficulty. Clinical reviews and prescribing information consistently describe its main benefit as reducing sleep latency rather than improving sleep maintenance.
How It Works
Zaleplon enhances the action of gamma-aminobutyric acid (GABA) at GABAA receptors in the central nervous system, producing a calming and sleep-promoting effect. Because it is rapidly absorbed and has a short half-life, its effects are mainly concentrated around sleep initiation.
Important Safety Information
Zaleplon should not be used in people with known hypersensitivity to zaleplon or to any component of the formulation. It is also associated with clinically important risks seen with sedative-hypnotics, including next-day impairment, additive sedation with other central nervous system depressants, and complex sleep-related behaviours. Prescribing information warns about use with alcohol and other sedating medicines, as well as the potential for dependence, tolerance, and withdrawal symptoms with hypnotic use.
Possible Side Effects
Common adverse effects reported with zaleplon include headache, dizziness, drowsiness, and a sense of abnormal sedation or fatigue. More serious reactions can include confusion, memory impairment, parasomnias such as sleep-walking or other complex behaviours, allergic reactions, and respiratory depression in vulnerable patients.
Scientific Evidence
Peer-reviewed reviews conclude that zaleplon is effective for reducing the time needed to fall asleep and is less useful for sleep maintenance because of its short duration of action. Published clinical evidence also suggests a relatively low rate of next-day residual effects compared with some other hypnotics, although safety concerns typical of sedative medicines still apply.
Medical Information Notice
This page is an educational summary based on sources available at the time of review and does not replace the official patient leaflet or an individual assessment by a qualified healthcare professional.
Medical Sources
- U.S. FDA / DailyMed — Zaleplon Capsules, prescribing information. View source
- M. Dooley et al. — “Zaleplon: a review of its use in the treatment of insomnia.” Drugs. 2000. View PubMed article
